Market Access
Position Your Organization for Growth With IQVIA Gross‑to‑Net
Margin pressures continue to grow and impact stakeholders across the pharmaceutical industry. With changing public policy, restrictive formulary designs and revenue leakage, the industry has been pushed into the new margin era, where profit margins are shrinking and creating uncertainty for the future. As a result, manufacturers are seeking precision analytics to scrutinize their business decisions. Powered by IQVIA Connected Intelligence™, our industry-leading solutions and data hub are designed to meet the industry challenges with respect to the most accurate and optimized gross-to-net methodologies.
Watch our video to explore how our experts here at IQVIA can partner with you to address all of your gross-to-net needs.